about
Vaccines: from empirical development to rational designMitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Approaches to vaccines against Orientia tsutsugamushiVaccines for the 21st centuryImmunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesTRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivoDisruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasitesMarket implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles.Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine.Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector.pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.mRNA vaccine delivery using lipid nanoparticles.Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection.Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vectorLack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells.Immunotherapy for the treatment of prostate cancer.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs.Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in miceIn vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizationsVirological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyPer-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in micePrime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.The impact of pre-existing memory on differentiation of newly recruited naive CD8 T cellsNew challenges in modern vaccinologyThe signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation.No acquisition: a new ambition for HIV vaccine development?Trypanosoma cruzi as an effective cancer antigen delivery vector.Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in MiceSuperior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Approaching the target: the path towards an effective malaria vaccine.High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvantA changing landscape in castration-resistant prostate cancer treatment
P2860
Q21089599-05027A0E-C12F-4BD8-BE8A-995930AB3834Q26748776-3B700A54-4C4F-49EA-8A47-50142431765CQ26849239-B7879D21-8597-44D1-AC84-0D249D907C96Q27007529-0F2BD359-CADC-43C1-AC6D-B3141A76E09BQ27319783-B127E65B-E14A-49C5-AABD-B2D0DF64F747Q27332276-FA5C49CB-6B1D-42B4-9604-84205CF85C8AQ27974558-F3312D43-A95C-4C91-B07E-409C0C2AE07CQ30375380-3A59A9FC-7E7C-4207-9D04-14AC4169C081Q30423733-31BE8331-1533-4AA5-AD23-860700898DEBQ30877907-30163364-1078-4368-B917-D61E9F016E3EQ31159398-E963CD42-7C7B-4657-9E54-9BABE1AEF285Q33648649-851C07A8-E6C4-47C6-B8E5-995444D54BDEQ33703757-AABFD49B-8A97-45B2-91D0-3BE913BDAA32Q33711685-8226A1A3-5791-4B04-BF9D-B49CD5E9A0C6Q34105274-5CA1FD1F-2002-4783-9893-10A5DD6E0270Q34166320-56D0A268-E614-487F-A3AA-9E577A654F7BQ34168631-4ED85411-3010-4879-B44B-45130D8BF8D4Q34186928-061896BD-9359-47E2-9E09-E2A1E7956A56Q34349745-352C2435-FC35-471B-A9F9-5600697C3C25Q34500100-F91FFC78-F416-4494-9DEB-4994032B7881Q34510430-A53A1731-AB26-4414-ABEA-F80DF529BBCEQ34518201-D9BDEDC1-FA93-42CE-BE49-5B6C8FC49C39Q34593874-EB5227CF-C0BB-497C-9901-0B5BA6C213C5Q35069876-8328EC41-C1D2-475F-B79D-EFB0ACAAE86AQ35117688-55D49114-A05A-4924-AA6E-33BD92BEA1D2Q35160124-E44A93BB-C2A4-49D9-B3D4-C9322F37ABA9Q35204687-5511F93F-8FB0-4496-ADC4-C07033A2009DQ35218614-E66C5959-627A-47D4-BE96-7BC5CE45FB01Q35271066-C682B21D-580C-4F7B-8725-D32CA1FD69BBQ35523289-AAADFF38-B039-470F-BD80-D0456BC52C85Q35534563-C9C956E3-D636-4D82-8E80-6D7F092F4CDDQ35621200-BC1FBF4C-2B79-49C8-892E-5295938139E2Q35666180-11949B1A-9721-4D81-8761-D8475CFED3C8Q35826665-B8D1D902-D505-4A9F-9DFE-1BED0426C1C3Q35861251-48BA9F58-17F2-478D-9EE7-5F200BA6AC48Q35868091-6211173B-84F0-4467-A115-600D4DCE49E2Q35924716-690DBAE3-B2EB-4217-ACC8-22FD13863DC0Q35973549-82F9F4E3-B206-46FF-8976-468432FB3BC1Q36085370-9F343C09-14EF-425F-BA8C-B1CB7EE98D49Q36101308-445CBDD3-8C1F-41EB-9B96-A8C3098E372A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunologic basis of vaccine vectors.
@en
Immunologic basis of vaccine vectors.
@nl
type
label
Immunologic basis of vaccine vectors.
@en
Immunologic basis of vaccine vectors.
@nl
prefLabel
Immunologic basis of vaccine vectors.
@en
Immunologic basis of vaccine vectors.
@nl
P1433
P1476
Immunologic basis of vaccine vectors.
@en
P2093
Margaret A Liu
P304
P356
10.1016/J.IMMUNI.2010.10.004
P407
P577
2010-10-01T00:00:00Z